• Why Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock is listed among top recommendations - 2025 Market Overview & Community ... newser.com Fri, 03 Oct 2025 05:49:51 GMT
• What dividend safety rating applies to Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock - 2025 Trade Ideas & Consistent Grow... newser.com Wed, 01 Oct 2025 14:34:03 GMT
• How Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock responds to bond market - 2025 Retail Activity & Weekly High Momentum P... newser.com Tue, 30 Sep 2025 05:46:24 GMT
• Why Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock stays on top picks - Analyst Downgrade & Weekly Top Gainers Alerts newser.com Tue, 30 Sep 2025 04:40:01 GMT
• Why Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock is listed among top recommendations - Jobs Report & Weekly Breakout Opp... newser.com Mon, 29 Sep 2025 22:40:05 GMT
• How Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock responds to bond market newser.com Mon, 29 Sep 2025 19:09:00 GMT
• What dividend safety rating applies to Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock - Trend Reversal & Accurate Intraday... newser.com Mon, 29 Sep 2025 17:04:24 GMT
• Is Chemomab Therapeutics Ltd Common Stock 2QV0 a good long term investment - Covered Call Writing & Rapid Capital Trading Plans earlytimes.in Sun, 28 Sep 2025 22:56:47 GMT
• What analysts say about Chemomab Therapeutics Ltd Common Stock 2QV0 stock - Stock Rotation Strategies & Small Capital Investment T... earlytimes.in Sun, 28 Sep 2025 08:15:06 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock remains top rated - earnings risk summary & reliable price breakout sig... newser.com Sun, 28 Sep 2025 01:40:21 GMT
• How Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock responds to bond market - 2025 Price Action Summary & Long-Term Growth ... newser.com Sat, 27 Sep 2025 21:48:43 GMT
• What dividend safety rating applies to Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock - July 2025 Summary & Proven Capital... newser.com Sat, 27 Sep 2025 19:10:05 GMT
• What dividend safety rating applies to Chemomab Therapeutics Ltd. (Common Stock) (2QV0) stock - Weekly Gains Report & Growth Focus... newser.com Fri, 26 Sep 2025 20:25:51 GMT
• how chemomab therapeutics ltd. (common stock) (2qv0) stock responds to bond market - exit point & smart investment allocation insi... newser.com Fri, 26 Sep 2025 18:47:25 GMT
• why chemomab therapeutics ltd. (common stock) (2qv0) stock is listed among top recommendations - july 2025 wrapup & daily volume s... newser.com Fri, 26 Sep 2025 17:29:48 GMT
• chemomab therapeutics announces first quarter 2022 financial results and provides corporate update PR Newswire Thu, 25 Sep 2025 06:10:00 GMT
• oppenheimer maintains chemomab therapeutics(cmmb.us) with buy rating, raises target price to $25 富途牛牛 Thu, 28 Aug 2025 07:00:00 GMT
• oppenheimer raises chemomab stock price target to $25 on m&a potential by investing.com Investing.com South Africa Thu, 28 Aug 2025 04:27:10 GMT
• Oppenheimer raises Chemomab stock price target to $25 on M&A potential Investing.com Wed, 27 Aug 2025 07:00:00 GMT
• oppenheimer maintains chemomab therapeutics(cmmb.us) with buy rating, raises target price to $25 富途牛牛 Wed, 27 Aug 2025 07:00:00 GMT
• chemomab therapeutics price target raised to $25 from $10 at oppenheimer TipRanks Wed, 27 Aug 2025 07:00:00 GMT
• Chemomab Therapeutics Announces ADS Ratio Change Effective August 26, 2025 TipRanks Tue, 26 Aug 2025 07:00:00 GMT
• chemomab therapeutics price target raised to $25 from $10 at oppenheimer MSN Tue, 26 Aug 2025 07:00:00 GMT
• chemomab therapeutics announces ads ratio change effective august 26, 2025 TipRanks Mon, 25 Aug 2025 00:14:43 GMT
• chemomab therapeutics announces ads ratio change effective august 26, 2025 The Globe and Mail Sat, 23 Aug 2025 20:30:00 GMT
• chemomab announces appointment of mitchell l. jones, md, phd as vice president of corporate development & strategy Quantisnow Sat, 23 Aug 2025 01:29:04 GMT
• chemomab therapeutics announces ads ratio change effective august 26, 2025 TipRanks Fri, 22 Aug 2025 20:28:39 GMT
• chemomab to present at h.c. wainwright global investment conference sept. 5. AInvest Thu, 21 Aug 2025 12:06:34 GMT
• Chemomab Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference Yahoo Finance Thu, 21 Aug 2025 07:00:00 GMT
• Clinical-Stage Biotech Chemomab to Showcase Fibro-Inflammatory Pipeline at Global Investment Conference Stock Titan Thu, 21 Aug 2025 07:00:00 GMT
• Chemomab, FDA align on key aspects of nebokitug development Liver Disease News Wed, 20 Aug 2025 07:00:00 GMT
• maxim group maintains chemomab therapeutics(cmmb.us) with buy rating, maintains target price $7 富途牛牛 Fri, 15 Aug 2025 07:00:00 GMT
• chemomab therapeutics: advancing cm-101 with strategic financial optimizations and fda support TipRanks Fri, 15 Aug 2025 07:00:00 GMT
• chemomab therapeutics announces second quarter 2025 financial results and provides corporate update GlobeNewswire Fri, 15 Aug 2025 04:35:50 GMT
• Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update Yahoo Finance Thu, 14 Aug 2025 07:00:00 GMT
• chemomab's psc drug nebokitug gets fda backing for phase 3 program as company seeks strategic partner Stock Titan Thu, 14 Aug 2025 07:00:00 GMT
• chemomab therapeutics reports q2 eps 0.4c vs 0.013c last year TipRanks Thu, 14 Aug 2025 07:00:00 GMT
• chemomab therapeutics to carry out 1-for-4 reverse stock split on august 26th, 2025 富途牛牛 Sat, 09 Aug 2025 07:02:56 GMT
• Chemomab Therapeutics To Carry Out 1-for-4 Reverse Stock Split On August 26th, 2025 富途牛牛 Fri, 08 Aug 2025 07:00:00 GMT
• mersana therapeutics (nasdaq:mrsn) and chemomab therapeutics (nasdaq:cmmb) head to head analysis Defense World Tue, 05 Aug 2025 07:00:00 GMT
• chemomab therapeutics enters sales agreement with lifesci capital The Globe and Mail Sat, 26 Jul 2025 07:00:00 GMT
• chemomab therapeutics enters sales agreement with lifesci capital TipRanks Fri, 25 Jul 2025 07:00:00 GMT
• chemomab therapeutics announces key decisions from annual shareholders meeting, ceo awarded restricted share units AInvest Wed, 02 Jul 2025 07:00:00 GMT
• chemomab therapeutics announces key decisions from annual shareholders meeting TipRanks Tue, 01 Jul 2025 07:00:00 GMT
• chemomab therapeutics announces data from phase 2 spring trial of nebokitug TipRanks Tue, 01 Jul 2025 06:50:57 GMT
• Chemomab Therapeutics Announces Positive Phase 2 SPRING Trial Results for Nebokitug as Promising Treatment for Primary Sclerosing ... Nasdaq Mon, 30 Jun 2025 07:00:00 GMT
• breakthrough psc treatment: nebokitug phase 2 data shows multiple disease-modifying benefits Stock Titan Mon, 30 Jun 2025 07:00:00 GMT
• chemomab announces oral presentation of positive nebokitug GlobeNewswire Mon, 30 Jun 2025 07:00:00 GMT
• chemomab therapeutics announces data from phase 2 spring trial of nebokitug TipRanks Mon, 30 Jun 2025 07:00:00 GMT
• chemomab therapeutics, ltd. announces oral presentation of positive nebokitug phase 2 clinical data in primary sclerosing cholangi... MarketScreener Mon, 30 Jun 2025 07:00:00 GMT
• cmmb’s market whiplash: -34.81% ytd decline, -15.11% plunge in 30 days investchronicle.com Wed, 18 Jun 2025 07:00:00 GMT
• chemomab therapeutics (nasdaq:cmmb) shares up 2.5% – time to buy? Defense World Tue, 17 Jun 2025 07:00:00 GMT
• chemomab therapeutics advances phase 3 development with fda approval on key milestones AInvest Sun, 15 Jun 2025 07:00:00 GMT
• chemomab obtained feedback from two recent fda meetings on nebokitug TipRanks Wed, 11 Jun 2025 19:31:38 GMT
• chemomab reports positive feedback from two recent fda GlobeNewswire Wed, 11 Jun 2025 07:00:00 GMT
• fda backs chemomab's nebokitug phase 3 plans: major regulatory win for psc treatment Stock Titan Wed, 11 Jun 2025 07:00:00 GMT
• cmmb advances toward phase 3 with fda approval on key milestones GuruFocus Wed, 11 Jun 2025 07:00:00 GMT
• chemomab therapeutics to present at the h.c. wainwright 25th annual global investment conference The Globe and Mail Tue, 10 Jun 2025 18:26:54 GMT
• chemomab announces nebokitug awarded new patent protection in china, russia TipRanks Tue, 03 Jun 2025 13:44:40 GMT
• chemomab therapeutics says nebokitug awarded new patent protections in china, russia MarketScreener Tue, 03 Jun 2025 12:43:46 GMT
• cmmb gains new patent protections for lead product nebokitug | cmmb stock news GuruFocus Tue, 03 Jun 2025 12:17:19 GMT
• chemomab announces new patent awards for its first-in-class GlobeNewswire Tue, 03 Jun 2025 07:00:00 GMT
• breakthrough psc drug patent: chemomab's nebokitug could be first-ever treatment for fatal liver disease Stock Titan Tue, 03 Jun 2025 07:00:00 GMT
• rckt stock tanks on patient death in danon disease study The Globe and Mail Wed, 28 May 2025 07:00:00 GMT
• chemomab therapeutics announces annual general meeting for july 2025 TipRanks Tue, 27 May 2025 07:00:00 GMT
• chemomab prepares for annual shareholder meeting by investing.com Investing.com Canada Tue, 27 May 2025 07:00:00 GMT
• chemomab therapeutics (nasdaq:cmmb) shares up 0.4% – should you buy? Defense World Sat, 24 May 2025 18:15:24 GMT
• oppenheimer issues pessimistic forecast for chemomab therapeutics (nasdaq:cmmb) stock price Defense World Sun, 18 May 2025 06:46:57 GMT
• chemomab therapeutics: promising prospects with streamlined path to approval and strategic advancements TipRanks Sat, 17 May 2025 17:59:33 GMT
• chemomab therapeutics price target lowered to $10 from $11 at oppenheimer TipRanks Sat, 17 May 2025 10:48:12 GMT
• oppenheimer maintains outperform rating on chemomab therapeutics, lowers price target to $10.00 usd. AInvest Sat, 17 May 2025 07:00:00 GMT
• oppenheimer adjusts chemomab therapeutics price target to $10 from $11, maintains outperform rating marketscreener.com Fri, 16 May 2025 12:45:18 GMT
• cmmb price target lowered amid positive trial results | cmmb sto GuruFocus Fri, 16 May 2025 07:00:00 GMT
• cmmb: oppenheimer maintains outperform rating but lowers price t GuruFocus Fri, 16 May 2025 07:00:00 GMT
• chemomab therapeutics price target lowered to $10 from $11 at oppenheimer TipRanks Fri, 16 May 2025 07:00:00 GMT
• cmmb achieves milestones with fda pathway and positive trial data | cmmb stock news GuruFocus Thu, 15 May 2025 12:50:02 GMT
• chemomab therapeutics reports q1 eps $0.007 vs $0.014 last year TipRanks Thu, 15 May 2025 12:18:32 GMT
• Chemomab Therapeutics Announces First Quarter 2025 Financial Results and Provides Corporate Update Yahoo Finance Thu, 15 May 2025 07:00:00 GMT
• chemomab psc drug shows strong 48-week results, fda approval path confirmed | cmmb stock news Stock Titan Thu, 15 May 2025 07:00:00 GMT
• chemomab therapeutics advances nebokitug towards phase 3 after positive trial results TipRanks Thu, 15 May 2025 07:00:00 GMT
• chemomab leadership changes signal strategic momentum following positive clinical results Barchart.com Mon, 12 May 2025 02:10:00 GMT
• dr. michael lebow scholarship announces scholarship to cultivate future medical leaders Barchart.com Mon, 12 May 2025 02:10:00 GMT
• old patrolman guard services expands security access nationwide Barchart.com Mon, 12 May 2025 02:10:00 GMT
• chemomab announces new medical and clinical appointments The Globe and Mail Sun, 11 May 2025 16:21:00 GMT
• chemomab leadership changes signal strategic momentum following positive clinical results Barchart.com Sun, 11 May 2025 07:00:00 GMT
• chemomab leadership changes signal strategic momentum following positive clinical results Barchart.com Thu, 08 May 2025 19:55:00 GMT
• hearing notice - ciro to hold a settlement hearing for scott nicolas zurevinski Barchart.com Wed, 07 May 2025 17:43:46 GMT
• chief mountain port of entry opens for the summer season Barchart.com Wed, 07 May 2025 16:44:10 GMT
• dayvid comes full circle with cinematic new single ‘see you soon’ Barchart.com Wed, 07 May 2025 14:44:00 GMT
• this unlikely company is the top-rated ai stock to buy in may 2025 Barchart.com Wed, 07 May 2025 11:30:00 GMT
• shiba inu’s (shib) potential fades and price drops by 3.37%, but analysts expect ruvi ai (ruvi) to hit $2.00 and turn $400 into $8... Barchart.com Wed, 07 May 2025 05:58:00 GMT
• support.com and greenidge generation holdings inc. announce update on merger closing Barchart.com Tue, 06 May 2025 15:33:00 GMT
• grain markets firm in the overnight and early morning trade. will it last through today's session? Barchart.com Tue, 06 May 2025 15:33:00 GMT
• dayvid comes full circle with cinematic new single ‘see you soon’ Barchart.com Tue, 06 May 2025 15:33:00 GMT
• shareholder alert: levi & korsinsky notifies aldeyra therapeutics, inc.(aldx) investors of a class action lawsuit and upcoming dea... Barchart.com Tue, 06 May 2025 15:33:00 GMT
• chemomab leadership changes signal strategic momentum following positive clinical results Barchart.com Tue, 06 May 2025 15:33:00 GMT
• live nation entertainment stock: analyst estimates & ratings Barchart.com Tue, 06 May 2025 15:33:00 GMT
• brazils rising conservative force: leonardo avalanche leads the rights resurgence Barchart.com Tue, 06 May 2025 15:33:00 GMT
• unlock productivity in 2025: 5 innovative ways to use a free online notepad Barchart.com Tue, 06 May 2025 15:33:00 GMT
• chemomab therapeutics: promising phase 2 data and attractive entry point justify buy rating TipRanks Tue, 06 May 2025 14:47:42 GMT
• recovery support in muskoka: a closer look at rehabilitation services in ontario Barchart.com Mon, 05 May 2025 18:28:00 GMT
• chemomab leadership changes signal strategic momentum following positive clinical results Barchart.com Mon, 05 May 2025 14:37:00 GMT
• chemomab therapeutics announces presentation of phase 2 data of cm-101 TipRanks Mon, 05 May 2025 13:20:02 GMT
• chemomab therapeutics ltd expected to post a loss of 1 cent a share - earnings preview TradingView Mon, 05 May 2025 12:04:06 GMT
• chemomab announces presentation of positive nebokitug phase GlobeNewswire Mon, 05 May 2025 07:00:00 GMT
• nebokitug shows promise in psc treatment in phase 2 trial Investing.com Mon, 05 May 2025 07:00:00 GMT
• breakthrough in psc treatment: new drug shows significant disease-modifying potential in phase 2 trial Stock Titan Mon, 05 May 2025 07:00:00 GMT
• Biotech Alert: Searches spiking for these stocks today Yahoo Finance Thu, 01 May 2025 07:00:00 GMT
• united therapeutics (uthr) to report earnings tomorrow: here is what to expect Barchart.com Tue, 29 Apr 2025 07:00:00 GMT
• ecosynthetix to host 2025 first quarter results conference call Barchart.com Tue, 29 Apr 2025 07:00:00 GMT
• careframe launches open-source platform to streamline healthcare studies Barchart.com Tue, 29 Apr 2025 07:00:00 GMT
• chemomab therapeutics reports positive data on liver disease treatment marketscreener.com Mon, 28 Apr 2025 17:17:12 GMT
• chemomab therapeutics reports new clinical data at easl 2025 on nebokitug TipRanks Mon, 28 Apr 2025 13:44:30 GMT
• chemomab reports new positive clinical data at easl 2025 GlobeNewswire Mon, 28 Apr 2025 07:00:00 GMT
• breakthrough phase 2 data: new drug shows promising results for rare liver disease psc treatment Stock Titan Mon, 28 Apr 2025 07:00:00 GMT
• chemomab therapeutics reports promising phase 2 spring trial data for nebokitug, showing significant improvements in biomarkers fo... Nasdaq Mon, 28 Apr 2025 07:00:00 GMT
• cracker barrel (cbrl): buy, sell, or hold post q4 earnings? Barchart.com Mon, 28 Apr 2025 07:00:00 GMT
• chemomab therapeutics ltd. (nasdaq:cmmb) sees significant drop in short interest Defense World Mon, 28 Apr 2025 06:01:38 GMT
• head-to-head survey: evofem biosciences (nasdaq:evfm) vs. chemomab therapeutics (nasdaq:cmmb) Defense World Thu, 24 Apr 2025 05:32:12 GMT
• nebokitug shines in clinical trials: chemomab therapeutics' breakthrough in fibro-inflammatory diseases AInvest Mon, 21 Apr 2025 07:00:00 GMT
• chemomab therapeutics to present nebokitug clinical data at upcoming scientific conferences GlobeNewswire Mon, 21 Apr 2025 07:00:00 GMT
• groundbreaking psc treatment data: nebokitug shows promise in multiple clinical trials - key findings revealed Stock Titan Mon, 21 Apr 2025 07:00:00 GMT
• how to buy research peptides in 2025: navigating the legal and responsible options Barchart.com Thu, 17 Apr 2025 07:00:00 GMT
• strava to acquire runna, a leading running training app Barchart.com Thu, 17 Apr 2025 07:00:00 GMT
• chemomab announces new medical and clinical appointments markets.businessinsider.com Wed, 16 Apr 2025 04:01:03 GMT
• form 20-f - annual and transition report of foreign private issuers [sections 13 or 15(d)] ADVFN Tue, 15 Apr 2025 15:33:59 GMT
• chemomab therapeutics names david weiner as interim chief medical officer marketscreener.com Tue, 15 Apr 2025 14:53:07 GMT
• chemomab announces new medical and clinical appointments FinancialContent Tue, 15 Apr 2025 07:00:00 GMT
• chemomab bolsters medical team as revolutionary psc drug advances toward fda Stock Titan Tue, 15 Apr 2025 07:00:00 GMT
• cmmb - chemomab therapeutics ltd latest stock news & market updates Stock Titan Tue, 15 Apr 2025 07:00:00 GMT
• chemomab announces key leadership changes amid successful trial completion TipRanks Tue, 15 Apr 2025 07:00:00 GMT
• earnings preview: what to expect from domino's pizza's report Barchart.com Tue, 15 Apr 2025 07:00:00 GMT
• chemomab therapeutics to present at upcoming scientific conferences Seeking Alpha Tue, 15 Apr 2025 05:32:59 GMT
• i’m from launches new black rice toner: a revolutionary addition to the rice skincare trend Barchart.com Thu, 10 Apr 2025 07:00:00 GMT
• chemomab therapeutics to report third quarter 2024 financial results and provide a business update Quantisnow Fri, 04 Apr 2025 03:30:23 GMT
• nebokitug shows sustained benefits for moderate, advanced psc Liver Disease News Wed, 02 Apr 2025 07:00:00 GMT
• promising phase 3 prospects and strategic study design justify buy rating for chemomab therapeutics TipRanks Fri, 28 Mar 2025 07:00:00 GMT
• nebokitug shows promise in psc treatment trial by investing.com Investing.com South Africa Thu, 27 Mar 2025 20:40:38 GMT
• is chemomab therapeutics ltd adr (nasdaq: cmmb) a good pick for new investors now? Stocks Register Thu, 27 Mar 2025 20:03:45 GMT
• chemomab therapeutics' touts positive data from experimental drug for chronic liver disease Benzinga Thu, 27 Mar 2025 19:18:23 GMT
• chemomab reports positive phase 2 data for nebokitug in primary sclerosing cholangitis Nasdaq Thu, 27 Mar 2025 14:02:00 GMT
• Chemomab Reports Positive Results in Nebokitug Phase 2 PSC Open Label Extension Trial Showing Continued Broad and Substantial Impr... GlobeNewswire Thu, 27 Mar 2025 07:00:00 GMT
• chemomab’s nebokitug shows promising phase 2 results for psc TipRanks Thu, 27 Mar 2025 07:00:00 GMT
• game-changing psc treatment cuts disease progression by 80% in latest clinical data Stock Titan Thu, 27 Mar 2025 07:00:00 GMT
• chemomab therapeutics reports results in nebokitug phase 2 psc ole trial TipRanks Thu, 27 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in tuesday's after-market session Benzinga Tue, 25 Mar 2025 21:05:55 GMT
• chemomab therapeutics updates ads offering under sales agreement TipRanks Thu, 20 Mar 2025 21:58:56 GMT
• chemomab therapeutics reports 2024 financial results and progress TipRanks Fri, 07 Mar 2025 04:15:43 GMT
• chemomab therapeutics announces new scientific presentation on nebokitug TipRanks Thu, 06 Mar 2025 14:30:01 GMT
• can this novel antibody transform systemic sclerosis treatment? new clinical evidence emerges StockTitan Thu, 06 Mar 2025 08:00:00 GMT
• cmmb - chemomab therapeutics ltd latest stock news & market updates StockTitan Thu, 06 Mar 2025 08:00:00 GMT
• chemomab therapeutics reports 2024 financial results and progress TipRanks Thu, 06 Mar 2025 08:00:00 GMT
• CM-101 (nebokitug) set for primary sclerosing cholangitis Phase 3 trial Liver Disease News Wed, 05 Mar 2025 08:00:00 GMT
• chemomab therapeutics ltd reports results for the quarter ended december 31 - earnings summary TradingView Wed, 05 Mar 2025 08:00:00 GMT
• chemomab therapeutics announces year end and fourth quarter GlobeNewswire Mon, 03 Mar 2025 08:00:00 GMT
• chemomab therapeutics reports 2024 financial results and advances psc treatment TipRanks Mon, 03 Mar 2025 08:00:00 GMT
• fda greenlights chemomab's path to market for rare liver disease treatment - what's next? Stock Titan Mon, 03 Mar 2025 08:00:00 GMT
• chemomab therapeutics ltd expected to post a loss of 8 cents a share - earnings preview TradingView Mon, 03 Mar 2025 08:00:00 GMT
• chemomab therapeutics reports q4 eps (1c) vs. (1c) last year TipRanks Mon, 03 Mar 2025 08:00:00 GMT
• chemomab therapeutics (cmmb) to release earnings on thursday Defense World Thu, 27 Feb 2025 08:11:36 GMT
• chemomab therapeutics price target raised to $7 from $4 at maxim TipRanks Thu, 20 Feb 2025 19:47:17 GMT
• chemomab therapeutics (cmmb) stock price, news & analysis MarketBeat Thu, 20 Feb 2025 08:00:00 GMT
• how analysts predict chemomab therapeutics ltd adr (cmmb) will perform this quarter? US Post News Wed, 19 Feb 2025 17:33:37 GMT
• Chemomab Therapeutics Announces FDA Alignment on Phase 3 Trial Design for Nebokitug as Potential First Treatment for Primary Scler... Nasdaq Wed, 19 Feb 2025 08:00:00 GMT
• chemomab completes successful end-of-phase 2 meeting and aligns with fda on clear and efficient path to potential regulatory appro... GlobeNewswire Wed, 19 Feb 2025 08:00:00 GMT
• chemomab aligns with fda on phase 3 trial path for psc drug TipRanks Wed, 19 Feb 2025 08:00:00 GMT
• fda fast-tracks revolutionary psc drug: single phase 3 trial could change rare disease treatment Stock Titan Wed, 19 Feb 2025 08:00:00 GMT
• chemomab completes end-of-phase 2 meeting with the fda for cm-101 TipRanks Wed, 19 Feb 2025 08:00:00 GMT
• chemomab therapeutics (nasdaq:cmmb) shares up 0.5% – should you buy? Defense World Thu, 06 Feb 2025 08:11:54 GMT
• chemomab ceo to present breakthrough ccl24 antibody at oppenheimer healthcare conference StockTitan Mon, 03 Feb 2025 12:00:00 GMT
• chemomab therapeutics to participate in oppenheimer 35th annual healthcare life sciences conference The Manila Times Mon, 03 Feb 2025 08:00:00 GMT
• are wall street analysts predicting amgen stock will climb or sink? Barchart.com Mon, 03 Feb 2025 08:00:00 GMT
• chemomab therapeutics to report fourth quarter and full year 202 GuruFocus.com Sun, 05 Jan 2025 23:24:05 GMT
• chemomab therapeutics (nasdaq:cmmb) trading up 16.2% – should you buy? Defense World Fri, 27 Dec 2024 08:00:00 GMT
• venter quickly grabs the reins back at human longevity; peter thiel backs upstart chemomab Endpoints News Thu, 05 Dec 2024 08:00:00 GMT
• Chemomab Therapeutics to Present at Oppenheimer's Movers in Rare Disease Summit on December 12, 2024 Quiver Quantitative Tue, 03 Dec 2024 08:00:00 GMT
• Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit The Manila Times Tue, 03 Dec 2024 08:00:00 GMT
• chemomab to participate in oppenheimer’s movers in rare disease summit GlobeNewswire Tue, 03 Dec 2024 08:00:00 GMT
• oral presentation at aasld the liver meeting® 2024 highlights broad clinical activity of chemomab’s cm-101 across multiple biomark... GlobeNewswire Tue, 19 Nov 2024 08:00:00 GMT
• chemomab's cm-101 shows promising phase 2 results in psc treatment trial StockTitan Tue, 19 Nov 2024 08:00:00 GMT
• chemomab highlights clincial activity of cm-101 at the liver meeting 2024 TipRanks Tue, 19 Nov 2024 08:00:00 GMT
• chemomab therapeutics aligns leadership incentives with shareholders TipRanks Mon, 18 Nov 2024 08:00:00 GMT
• Chemomab Therapeutics CEO Dr Adi Mor discusses Q3 results; progress with lead PSC treatment Proactive financial news Fri, 15 Nov 2024 08:00:00 GMT
• chemomab therapeutics ceo dr adi mor discusses q3 results; progress with lead psc treatment Proactive Investors Thu, 14 Nov 2024 08:00:00 GMT
• chemomab therapeutics announces third quarter 2024 financial results and provides corporate update Yahoo Finance Thu, 14 Nov 2024 08:00:00 GMT
• chemomab advances psc drug after positive phase 2 results, secures $10m funding StockTitan Thu, 14 Nov 2024 08:00:00 GMT
• chemomab’s positive trial results boost investor confidence TipRanks Thu, 14 Nov 2024 08:00:00 GMT
• chemomab therapeutics reports q3 eps (1c) vs (2c) last year TipRanks Thu, 14 Nov 2024 08:00:00 GMT
Chemomab Therapeutics Ltd(NASDAQ:CMMB) 
Chemomab Therapeutics Ltd. engages in the research and development of biological drugs for the treatment of inflammatory and fibrotic diseases. The company was formerly known as Anchiano Therapeutics Ltd. and changed its name to Chemomab Therapeutics Ltd. in March 16, 2021. Chemomab Therapeutics Ltd...
Share this website to your friends